Related Experiment Video
Updated: Jun 23, 2026
09:02
Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Genetic alterations in chronic lymphocytic leukaemia
1Departament de Ciències Fisiològiques II, IDIBELL-Universitat de Barcelona, Campus de Bellvitge, Pavelló de Govern, L'Hospitalet de Llobregat, Spain.
Summary
Chronic lymphocytic leukemia (CLL) is a genetically diverse cancer. This review details common genetic alterations and detection methods like FISH and MLPA for improved CLL diagnosis and understanding.
Area of Science:
- Hematology
- Genetics
- Oncology
Background:
- Chronic lymphocytic leukemia (CLL) is the most prevalent leukemia in adults in Western nations.
- CLL is characterized by significant genetic heterogeneity.
- Key genetic alterations include 13q14 deletions, 17p13 (TP53) deletions, 11q22-q23 (ATM) deletions, and trisomy 12.
Purpose of the Study:
- To review the spectrum of genetic alterations observed in CLL.
- To summarize the methodologies employed for detecting these genetic alterations in CLL.
Main Methods:
- Comparative Genomic Hybridisation (CGH) for genome-wide screening.
- Fluorescence In Situ Hybridisation (FISH) for targeted chromosomal analysis.
- Multiplex Ligation-dependent Probe Amplification (MLPA) for sensitive detection of copy number variations.
Main Results:
- Identified frequent genetic alterations in CLL: 13q14, 17p13 (TP53), 11q22-q23 (ATM), and trisomy 12.
- Highlighted the utility of CGH, FISH, and MLPA in characterizing CLL genetic landscape.
- Noted the existence of additional, less common genetic alterations in CLL.
Conclusions:
- Genetic heterogeneity is a hallmark of CLL.
- Accurate detection of genetic alterations is crucial for CLL diagnosis and management.
- Advancements in molecular techniques like MLPA enhance the detection capabilities for CLL genetic abnormalities.
Related Concept Videos
01:39Mutations
Overview
01:35Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...